Clinical Trial

Modulation of Molecular Fingerprinting in Pediatric Sepsis

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2014-02-03; most recent amendment 2025-11-07.
Status change: Not Yet Recruiting → Recruiting 2015-06-29
Trial Details
NCT Number NCT02055105
Lead Sponsor Phoenix Children's Hospital
Conditions Systemic Inflammatory Response Syndrome
Enrollment 50 participants
Start Date 2014-03
Primary Completion 2027-06 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2025-11-12